Kodiak Sciences (KOD)

• Market cap: $1.43B
• 1 day: -8.18%
• 5 days: -8.86%
• 1 month: -16.46%
• 3 months: 10.93%
• 6 months: 219.86%
• Year to date: -10.26%
• 1 year: 243.38%
• 5 years: -82.19%
• 10 years: 129.82%
• Sector: Healthcare
• Industry: Biotechnology

About: Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Employees: 121